Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | SB590885 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | JQ-1:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MLN2238 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |